blog
By: Mass Torts Attorneys Keith Donovan, Matt Fogg, and Ashley Curran
The recent settlement announcement in the Depo-Provera federal litigation is good news, but it does not resolve every Depo-Provera claim. Claims filed in state court, or claims that do not meet the settlement's specific eligibility criteria, fall outside the federal agreement. If that describes your situation, you still have legal options.
In June 2026, Pfizer reached a tentative agreement to resolve a substantial portion of the claims pending in the federal Depo-Provera MDL. That litigation, consolidated in the Northern District of Florida, includes thousands of cases from women across the country who allege that Pfizer failed to warn them about a link between long-term Depo-Provera use and meningioma, a type of brain tumor. We covered the announcement in more detail in our earlier article on the settlement announcement. The specific terms of the settlement, including the eligibility criteria that will determine which claims qualify, have not yet been made public. Plaintiff and defense counsel are still finalizing those details, and we will share updates as more information becomes available.
If you already have a pending claim, one practical step you can take now is confirming with your attorney which track your case is on, state or federal, so you know which set of deadlines and procedures actually applies to you.
Not every Depo-Provera lawsuit is filed in the federal MDL. Depending on the facts of your case, your attorney may advise filing in state court instead, and Delaware currently has hundreds of Depo-Provera cases moving through its own court system, entirely separate from the federal proceedings in Florida. State court cases follow Delaware's own procedural rules and timeline, and they are decided independently of whatever happens with the federal settlement. This is a normal feature of mass tort litigation. Large pharmaceutical cases often move forward on parallel tracks, one federal and one in the states, and a resolution on one track does not close the other.
If you have not yet filed a Depo-Provera claim, you are not out of options. A meningioma diagnosis does not have to be recent, and the timing of the federal settlement does not change your ability to pursue a claim. If you have not yet spoken with an attorney, the most important thing to understand is that filing deadlines apply independently of anything happening in the federal litigation, and those deadlines do not pause while the settlement is finalized.
A good first step is gathering what documentation you already have: pharmacy or prescription records showing your Depo-Provera use, and any imaging or medical records related to your meningioma diagnosis. You don't need a complete file to speak with an attorney, but having even partial records on hand can make that first conversation more productive.
Whether a case belongs in state or federal court depends on the specific facts involved, and that assessment is best made with an attorney who is closely following both tracks of this litigation. Our mass torts attorneys represent women in Depo-Provera claims both in Delaware and around the country, and we stay current on developments in the state court cases as well as the federal MDL.
If you were diagnosed with a meningioma after using Depo-Provera and have questions about your legal options, call us at 302.655.2599 or submit our contact form for a free, no-obligation consultation. We handle Depo-Provera cases on a contingency fee basis, so you pay nothing unless we recover compensation for you.
